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ABSTRACT MaternalinfectionduringpregnancywithawiderangeofRNAandDNAvirusesisassociatedwithincreasedriskfor
schizophreniaandautismintheiroffspring.Acommonfeatureintheseexposuresisthatvirusreplicationinducesinnateimmu-
nitythroughinteractionwithToll-likereceptors(TLRs).Weemployedamousemodelwhereinpregnantmicewereexposedto
polyinosinic-polycytidylicacid[poly(I · C)],asynthetic,double-strandedRNAmolecularmimicofreplicatingvirus.Poly(I·C)
inhibitedembryonicneuronalstemcellreplicationandpopulationofthesuperﬁciallayersoftheneocortexbyneurons.
Poly(I·C)alsoledtoimpairedneonatallocomotordevelopmentandabnormalsensorimotorgatingresponsesinadultoff-
spring.UsingToll-likereceptor3(TLR3)-deﬁcientmice,weestablishedthattheseeffectsweredependentonTLR3.Inhibitionof
stemcellproliferationwasalsoabrogatedbypretreatmentwiththenonsteroidalanti-inﬂammatorydrug(NSAID)carprofen,a
cyclooxygenase(COX)inhibitor.Ourﬁndingsprovideinsightsintomechanismsbywhichmaternalinfectioncaninducesubtle
neuropathologyandbehavioraldysfunction,andtheymaysuggeststrategiesforreducingtheriskofneuropsychiatricdisorders
subsequenttoprenatalexposurestopathogensandothertriggersofinnateimmunity.
IMPORTANCE Maternalinfectionduringgestationincreasestheriskofneuropsychiatricdisordersintheiroffspring.Further-
more,workinanimalmodelsindicatesthatpre-orneonatalinfectionswithawiderangeofvirusesresultsinsimilarneurode-
velopmentaloutcomes.Theseobservationsareconsistentwithamechanismwherebydamageismediatedthroughcommon
pathways.Exposureofpregnantmicetopolyinosinic-polycytidylicacid[poly(I·C)],asynthetic,double-strandedRNA(dsRNA)
molecularmimicofreplicatingvirus,inhibitedembryonicneuronalstemcellreplicationandledtobehavioralabnormalitiesin
theiroffspring.TheseeffectsweremediatedthroughTLR3andabrogatedbypretreatmentwiththenonsteroidalanti-
inﬂammatorydrug(NSAID)carprofen.Ourﬁndingsprovideinsightsintomechanismsbywhichmaternalinfectioncaninduce
subtleneuropathologyandmaysuggeststrategiesforreducingtheriskofneuropsychiatricdiseasesfollowingexposurestoin-
fectiousagentsandothertriggersofinnateimmunityduringgestation.
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I
nfection during pregnancy is associated with increased risk of
schizophrenia and autism in offspring (1). Several lines of evi-
dence indicate that the maternal immune response, rather than
direct infection of the fetus, may be responsible for the increased
incidenceofschizophreniaandautismintheoffspringofmothers
whosufferinfectionduringpregnancy(2,3).Inarodentmodelof
maternal immune activation, changes in the behavior and neuro-
anatomy of the offspring are elicited by injection into the mother
of synthetic double-stranded RNA (dsRNA) [poly(I · C)], a com-
pound that evokes an antiviral-like innate immune response (4,
5).Behavioralabnormalitiesobservedinthismodelareattributed
to the disrupted balance of proinﬂammatory and anti-
inﬂammatorycytokinesproducedinthemother(2).Usingasim-
ilarmousemodel,Meyeretal.showedinvivoevidenceforamod-
ulation of fetal dopaminergic system development by maternal
immune activation during pregnancy (6). Furthermore, injection
ofpoly(I·C)intopregnantrodentsinducesstronginnateimmune
responsesintheabsenceofaninfection,leadingtoabnormalgene
regulation and defective corticogenesis (5, 7). The breadth of mi-
crobes linked to neurodevelopmental abnormalities, including
rubella virus, cytomegalovirus, inﬂuenza virus, and herpes sim-
plex viruses, as well as Toxoplasma gondii and Corynebacterium
diphtheriae (2, 8–14), is consistent with a mechanism whereby
infection triggers innate immunity through common signaling
pathways.Leadingcandidatesformediatingtheseeffectsofpatho-
gens include the Toll-like receptors (TLRs). TLRs bind a wide
range of molecules associated with microbes, including ﬂagellar
structures, lipids and lipopeptides, zymosan, dsRNA molecules,
U-rich single-stranded RNA, and unmethylated CpG dinucleoti-
des (15, 16). Binding of these pathogen-associated molecular pat-
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events culminating in transcription of genes encoding interferon
and cytokines and other genes that contribute to both innate and
adaptive immunity (15). The dsRNA viral mimic poly(I · C) in-
ducesinnateimmunityviaToll-likereceptor3(TLR3)(17).TLRs
in mammals, like Toll receptors in Drosophila, also play pivotal
roles in development. TLR2, -3, -4, and -8 are expressed by glial
cells and neurons (17–21). Expression of TLR2 and -4 in adult
neural stem/progenitor cells (NPC) may inﬂuence their prolifer-
ation and differentiation. TLR2 deﬁciency in mice impairs adult
hippocampal neurogenesis, whereas the absence of TLR4 results
in enhanced proliferation and neuronal differentiation (22).
A fundamental feature of cerebral corticogenesis in mammals
is that positioning of neuronal constituents into horizontal and
vertical arrays deﬁnes their function and connectivity. As cortical
neurogenesis proceeds, newly generated neurons migrate radially
out of the proliferative neuroepithelial cell layers lining the lateral
ventricles, the ventricular zone (VZ) and subventricular zone
(SVZ) according to a precise schedule and along well-deﬁned
pathways (23, 24). Newly generated neurons migrate past cells
generated earlier to settle in progressively more superﬁcial layers,
ultimately forming a six-layered cortex wherein a neuron’s lami-
nar position is determined by its birth date (25, 26). Reports both
in schizophrenia of decreased numbers and/or incomplete clus-
tering of neurons in layer II of entorhinal, frontal, and cingulate
cortex(10)andinautismofmorenumerous,butsmallerandless
compact minicolumn architecture (27) indicate dysregulation in
later stages of corticogenesis.
During middle and late embryonic development, neocortical
neurons are generated from two distinct types of progenitor cells,
radial glia (RG) and intermediate progenitor cells (IPC). RG are
self-renewing stem cells that produce neurons and IPC, divide at
the ventricular surface, and express PAX6, a homeodomain tran-
scription factor. IPC produce only neurons and divide away from
the ventricular surface. Transition from RG to IPC is associated
with upregulation of TBR2, a T-domain transcription factor, and
downregulation of PAX6 (28–30). IPC contribute neurons to
mostorallcorticallayers(31);inlateneurogenesis,however,only
subventricular IPC give rise to upper-layer neurons.
Here we investigate the effects of TLR3 activation on neuro-
genesis and fetal neocortical development and on neonatal and
adult offspring behavior in a mouse model of gestational virus
infection. Gestational exposure to poly(I · C) induced cell cycle
arrest in RG, resulting in decreased neuronal output. Wild-type
(WT) offspring exposed to poly(I · C) exhibited impaired early
locomotor capacity; poly(I · C)-exposed WT adult offspring also
haddeﬁcitsinsensorimotorgating.Inhibitionofembryonicneu-
ronalprogenitorproliferationwasnotobservedinTLR3-deﬁcient
mice or in WT mice pretreated with the cyclooxygenase (COX)
inhibitor, carprofen.
RESULTS
Poly(I · C) treatment during gestation impairs early locomotor
development in neonates and PPI in adult mice. We observed
robustbehavioralchangesintheoffspringofWTmicereceivinga
single injection of 5 mg/ml of poly(I · C) on gestational day 16
(GD16);hence,allbehavioraltestingwasperformedwithanimals
receiving a single dose of poly(I · C) on GD16. WT pregnant
C57BL/6 mice were treated on GD16 with either poly(I · C)
(5 mg/kg of body weight) or phosphate-buffered saline (PBS).
Open-ﬁeldlocomotoractivitywastestedintheoffspringfromthe
treatedpregnantmiceonpostnatalday8.TheoffspringfromWT
pregnant mice exposed to poly(I · C) on GD16 had reduced loco-
motor activity on postnatal day 8 compared to WT PBS-injected
mice (n  37 to 40) (P  0.038 for the number of ﬂoor plane
movesbytheMann-WhitneyUtest)(Fig.1a).Theoffspringfrom
poly(I · C)-treated WT mice exhibited a deﬁcit in sensorimotor
gating, as measured by the prepulse inhibition (PPI) of the startle
response at 4 dB and 8 dB, but not at 2 dB or 16 dB (n  16 to 22)
(PPI values at 2 dB, P  0.183; PPI values at 4 dB, P  0.008;
PPI values at 8 dB, P  0.050; PPI values at 16 dB, P  0.128)
(Fig.1b).ThemeanpercentPPIacrossallprepulseintensitieswas
disrupted by prenatal poly(I · C) treatment in offspring from WT
dams(dosegroupmaineffect,P0.018;datanotshown).Sexdid
notinﬂuencethisdosegroupeffectonthemeanpercentPPI(data
not shown).
Poly(I·C)treatmentduringgestationinducesdefectivepro-
liferationinfetalcerebralcorticalcells.PregnantmiceonGD16
were treated with either poly(I · C) or PBS and injected with the
DNAreplicationmarker,bromodeoxyuridine(BrdU),tolabeldi-
viding cells in the proliferative zone, destined for superﬁcial cor-
tical layers 2 and 3 (23). Cell suspensions of dissociated cortex
obtained from embryos on GD18 were analyzed by ﬂow cytom-
FIG 1 Poly(I · C) treatment during gestation impairs early locomotor devel-
opment in neonates and prepulse inhibition (PPI) in adult mice. (a) WT
C57BL/6 pregnant mice were treated with either PBS or poly(I · C) (5 mg/kg)
ongestationalday16(GD16).Protoambulatorybehavioroftheoffspringfrom
pregnant mice treated with PBS or poly(I · C) was measured in an open-ﬁeld
paradigm. Data are presented as the number of ﬂoor plane (FP) moves exhib-
itedbythemiceonpostnatalday8.Thevaluesforthepoly(I·C)-treatedgroup
aresigniﬁcantlydifferent(P0.05bytheMann-WhitneyUtest)comparedto
the values for the PBS-treated control group as indicated by the bracket and
asterisk. The height of the box plot shows the interquartile range, and the
horizontal line indicates the median. The range is indicated by the error bars,
andthecirclesrepresentoutliervalues.(b)Sensorimotorgatingoftheacoustic
startle reﬂex was measured as a percentage of prepulse inhibition in the adult
offspring from WT C57BL/6 dams injected on GD16 with either PBS (white
bars)orpoly(I·C)(5mg/kg)(hatchedbars).Dataarepresentedasthepercent
PPI exhibited at each of the four prepulse intensity trials (2, 4, 8, and 16 dB
above background noise) by the mice during postnatal weeks 15 to 17. The
values for the poly(I · C)-treated group are signiﬁcantly different (P  0.05 by
Fisher’s protected least-signiﬁcant difference [PLSD] test) compared to the
valuesforthePBS-treatedcontrolgroupasindicatedbythebracketandaster-
isk.
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scatter (FSC) and side scatter (SSC) proﬁle (Fig. 2a). The progeny
of PBS-treated mice displayed two subpopulations of BrdU-
positive cells that differed in the amount of BrdU incorporated,
BrdUlow cells and BrdUhigh cells. Poly(I · C) treatment resulted in
a signiﬁcant decrease in the percentage of BrdUhigh cells (n  7; P
 0.002 by the Mann-Whitney U test) (Fig. 2b and d). No signif-
icant change in BrdUlow labeling was observed with poly(I · C)
treatment(Fig.2b).ThemeanﬂuorescentintensityofBrdUlabel-
ing was also decreased in cells isolated from pups of poly(I · C)-
treatedpregnantmice(n4;P0.034bytheMann-WhitneyU
test) (Fig. 2c).
Relativeimportanceofapoptosisandcellcyclearresttofetal
cerebral cortical cell development after poly(I · C) treatment
during gestation. We postulated that poly(I · C)-induced reduc-
tion in cortical cell proliferation could reﬂect apoptosis or cell
cycle arrest. To assess the contribution of apoptosis, we measured
the expression of activated caspase 3 in embryonic cerebral corti-
cal cells. Pregnant mice on GD16 were injected with BrdU after
treatment with either PBS or poly(I · C). Cell suspensions of dis-
sociated cortex obtained from embryos on GD18 were analyzed
using ﬂow cytometry. Poly(I · C) treatment resulted in a signiﬁ-
cant increase in the percentage of cells expressing activated
caspase3(n4)(P0.021bytheMann-WhitneyUtest)(Fig.3a
and b). Expression of caspase 3 alone is not pathognomic of cell
death.Indeed,weobservednodifferencesbetweenpoly(I·C)and
control groups when cells were gated according to their FSC and
side scatter proﬁles (data not shown) or 7-aminoactinomycin D
(7-AAD) staining (see Fig. S1 in the supplemental material).
Caspase 3 expression may also vary as a function of cell cycle
dynamics. To assess the effects of poly(I · C) on the cell cycle, we
treated pregnant mice with two different halogenated nucleotide
analogs at different time points. Pregnant mice were treated with
eitherPBSorpoly(I·C)andsimultaneouslyinjectedwith5-iodo-
2=-deoxyuridine(IdU)onGD16.After10hofIdUexposure,mice
received a single injection of 5-chloro-2=-deoxyuridine (CldU).
Cell suspensions of dissociated cortex obtained from pups on
postnatal day 0 (PND0) were analyzed using ﬂow cytometry for
the incorporation of IdU and CldU.
The interval between the injections allows the majority of cells
toexittheSphaseaftertheﬁrstnucleotideinjectionbutisshorter
than the whole cell cycle, ensuring that cells reentering the cell
cycle incorporate the second nucleotide (32). Poly(I · C) resulted
inareductionofthepercentageofcellsincorporatingbothnucle-
otide analogs (n  3t o4 )( P  0.034 by the Mann-Whitney U
test)(Fig.3c,toprightquadrant,andFig.3e).Thequadrantswere
deﬁnedonthebasisofstainingobservedwiththeantibodyisotype
controls (Fig. 3d). No change in the percentage of cells incorpo-
rating IdU was observed with poly(I · C) (Fig. 3c, top two quad-
rants, and Fig. 3e). This is consistent with the BrdU data obtained
with GD18 embryos wherein no change in total BrdU incorpora-
tion was observed (Fig. 2b). Taken together, these data suggest
that prenatal poly(I · C) induces cell cycle arrest in cortical cells.
Poly(I · C) treatment during gestation negatively regulates
the transition of PAX6 RG cells to TBR2 PAX6 IPC in a
TLR3-dependentmanner.Toevaluatetheeffectofpoly(I·C)on
neural stem/progenitor cells (NPC) proliferation, we quantitated
the intracellular expression of PAX6 and TBR2 in subtypes of
NPC, radial glia (RG) cells and intermediate progenitor cells
(IPC). Embryonic cerebral cortical cells were isolated on GD18
from pregnant dams injected with poly(I · C) and BrdU and ana-
lyzed by ﬂow cytometry for expression of TBR2 and PAX6.
FIG 2 Poly(I · C) treatment during gestation induces defective proliferation
in fetal cerebral cortical cells. Pregnant mice were treated with either PBS or
poly(I·C)on3consecutivedays(GD15toGD17)andinjectedwithbromode-
oxyuridine (BrdU) on GD16. Cerebral cortical cells were isolated from em-
bryosonGD18,andquantitationofBrdU-labeledcellswasperformedbyﬂow
cytometric analysis. (a) Viable cerebral cortical cells were gated according to
forward scatter (FSC) and side scatter (SSC) proﬁles. The percentage of live
cells (85.5%) is shown. 50K, 50,000. (b) Representative histogram showing
intracellularBrdUincorporationincerebralcorticalcells.Thenumbersabove
the brackets indicate the percentages of brightly labeled BrdU cells (BrdUhigh)
and a subpopulation of cells that incorporated low levels of BrdU (BrdUlow).
GatingfortheBrdU-positivecellswasbasedontheanti-BrdUantibodystain-
ing observed with cells obtained from mice that were not injected with BrdU
(negativecontrol).Anti-BrdUantibodyconjugatedtoallophycocyanin(APC)
(BrdU-APC) was used. (c) Representative histogram showing the mean ﬂuo-
rescence intensity (MFI) of BrdU-labeled cells represented as a percentage of
maximum BrdU incorporation. Values for the different groups are indicated
asfollows:PBS-treatedmice(redline),poly(I·C)-treatedmice(blueline),and
negative-control mice (gray line). The experiments were performed with ce-
rebral cortical cells isolated from embryos (n  7); data from one representa-
tivecortexareshown.(d)PercentageofBrdUhighcellsincerebralcorticalcells
frommicetreatedwithPBSorpoly(I·C).Resultsareexpressedaspercentages
oftotalgatedcells.Thevaluesforthepoly(I·C)-treatedgrouparesigniﬁcantly
different (P  0.05 by the Mann-Whitney U test) compared to the values for
the PBS-treated control group as indicated by the bracket and asterisk. The
height of the box plot shows the interquartile range, and the horizontal line
indicates the median. The range is indicated by the error bars, and the circles
represent outlier values.
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percentage of TBR2-positive (TBR2) PAX6-
positive(PAX6)IPC(n3)(P0.049bythe
Mann-Whitney U test) (Fig. 4a and e). The
mean ﬂuorescent intensity of TBR2 PAX6
IPC was also decreased in cells isolated from
pups of poly(I · C)-treated pregnant dams (n 
3) (P  0.049 by the Mann-Whitney U test)
(Fig.4c).Poly(I·C)treatmentresultedinacon-
comitant increase in the percentage of PAX6
RG cells (n  3) (P  0.049 by the Mann-
Whitney U test) (Fig. 4b and e). The mean ﬂuo-
rescent intensity of PAX6 RG also increased in
embryos of poly(I · C)-treated dams (n  3) (P
0.049bytheMann-WhitneyUtest)(Fig.4d).
These results are consistent with a mechanism
wherein poly(I · C) treatment inhibits the tran-
sitionofRGcellstoIPC,therebydecreasingcor-
tical NPC expansion.
TLR3-deﬁcient (TLR3/) mice were used
to assess the role of TLR3 in the poly(I · C)-
mediated inhibition of the transition of RG to
IPC. Embryonic cerebral cortical cells were iso-
latedfromWTandTLR3/damsinjectedwith
poly(I · C) and BrdU. Whereas poly(I · C) treat-
ment of WT dams resulted in decreased
TBR2PAX6IPC,decreasedmeanﬂuorescent
intensity of TBR2PAX6 IPC, and increased
PAX6RGcells,nodifferenceswereobservedin
the labeling patterns of embryonic cells isolated
from poly(I · C)-treated dams compared to
thosefromPBS-treated,TLR3/dams(Fig.4a
to e). The percentages of PAX6 (RG) cells and
of TBR2 PAX6 cells (IPC) were signiﬁcantly
reduced in poly(I · C)-treated WT mice versus
poly(I · C)-treated TLR/ mice (n  3) (P 
0.049 by the Mann-Whitney U test) (Fig. 4e).
Taken together, these results implicate TLR3
signaling in the impaired NPC proliferation in-
duced by poly(I · C) during late corticogenesis.
Poly(I · C) treatment during gestation in-
duces deﬁcits in cerebral cortical neurogen-
esis. To investigate whether poly(I · C) induced
long-term deﬁcits in cortical neurogenesis, we
examinedBrdU-labeledcellsfromthepostnatal
cerebral cortices of pups from WT C57BL/6
dams that had previously been injected with
poly(I · C) or PBS. Immunoﬂuorescence analy-
sis of coronal cortical slices (see Text S1 in the
supplemental material) showed that on PND0
and PND8, BrdU cells migrated towards the
pial surface and reached positions in cortical
layersIIandIII(seeFig.S5ainthesupplemental
material). On PND0, BrdU-positive cells were
found in the cortex of the progeny in the ven-
tricular, subventricular, and intermediary lay-
ers. On PND8, BrdU-labeled cells were re-
stricted to the cortical gray matter (see Fig. S5a
in the supplemental material). BrdU-labeled,
CUX1-labeledpyramidalneuronswerereduced
FIG 3 Relative importance of apoptosis and cell cycle arrest to fetal cerebral cortical cell
development after poly(I · C) treatment during gestation. (a) Pregnant mice were treated with
either PBS or poly(I · C) and injected with BrdU on GD16. Cerebral cortical cells were isolated
fromtheembryosonGD18,andquantiﬁcationofactivatedcaspase3-positive(caspase3)cells
was performed by ﬂow cytometric analysis. Representative histograms show intracellular acti-
vated caspase 3 cells in cerebral cortical cells. The numbers above the brackets indicate the
percentages of activated caspase 3 cells. Gating for the caspase 3 cells was based on the
staining observed with the isotype control. Experiments were performed with cerebral cortical
cells isolated from embryos (n  4); data from one representative cortex are shown. (b) Per-
centageofactivatedcaspase3cellsincerebralcortexfrommicetreatedwithPBSorpoly(I·C).
The values for the poly(I · C)-treated group are signiﬁcantly different (P  0.05 by the Mann-
Whitney U test) compared to the values for the PBS-treated control group as indicated by the
bracket and asterisk. (c) Pregnant mice were treated with either PBS or poly(I · C) and simul-
taneously injected with 5-iodo-2=-deoxyuridine (IdU) on GD16. After 10 h of IdU exposure,
micereceivedasingleinjectionof5-chloro-2=-deoxyuridine(CldU).IdUandCldUincorpora-
tion was quantiﬁed by ﬂow cytometry. Dot plots of IdU versus CldU cerebral cortical cells
fromembryosofPBS-orpoly(I·C)-injecteddamsareshown.(d)Isotypecontrol.Thenumbers
in the four quadrants indicate the percentages of each subpopulation. Gating for the IdU- or
CldU-positive cells was based on the staining observed with the isotype control. Experiments
were performed with cells isolated from embryos (n  3 to 4); data from one representative
cortex are shown. (e) Percentage of IdU and IdU CldU in cerebral cortical cells from mice
treated with PBS or poly(I · C). Results are expressed as percentages of total viable cells. The
valuesforPBS-treatedmice(whitebars)andpoly(I·C)-treatedmice(hatchedbars)areshown.
The values for the poly(I · C)-treated group are signiﬁcantly different (P  0.05 by the Mann-
Whitney U test) compared to the values for the PBS-treated control group as indicated by the
bracketandasterisk.Theheightoftheboxplotshowstheinterquartilerange,andthehorizontal
line indicates the median. The range is indicated by the error bars, and the circles represent
outliervalues.
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mice (see Fig. S5b and S5c in the supplemental material).
Treatment with the nonselective cyclooxygenase (COX) in-
hibitorcarprofenpreventspoly(I·C)-induceddecreaseincere-
bral cortical neurogenesis. To investigate whether blocking in-
ﬂammation could reduce deﬁcits in cortical neurogenesis
associated with poly(I · C), we examined BrdU-labeled cells iso-
lated from the postnatal cerebral cortices of pups from WT preg-
nant C57BL/6 mice that had previously been injected with
poly(I·C)orPBS,withorwith-
out the nonsteroidal anti-
inﬂammatory drug (NSAID),
carprofen (gestational days 15,
16, and 17). Cortical cells ob-
tained from the pups of these
dams on postnatal day 8, an
endpointofcorticalneurondif-
ferentiation, were analyzed for
BrdU incorporation by ﬂow cy-
tometry. Poly(I · C) treatment
alone resulted in a decreased
percentage of BrdU cells (4
pups obtained from 4 different
dams)(P0.021bytheMann-
Whitney U test) (Fig. 5a and c).
The mean ﬂuorescent intensity
of BrdU labeling was also re-
duced in pups from dams
treated with poly(I · C) alone (4
pups obtained from 4 different
dams)(P0.021bytheMann-
Whitney U test) (Fig. 5b). To
examine the effect of poly(I · C)
on the BrdU-labeled neurons
destined to occupy the upper
layers of the cerebral cortex, we
measured BrdU incorporation
into neurons expressing CUX1,
a marker of cortical layers II/III
(33, 34). The percentage of
CUX1 neurons labeled with
BrdU was reduced in offspring
obtained from dams treated
with poly(I · C) alone (4 pups
obtained from 4 different
dams)(P0.021bytheMann-
Whitney U test) (Fig. 5d and f).
The mean ﬂuorescent intensity
of BrdU labeling was also re-
duced in CUX1 neurons of
these pups (4 pups obtained
from 4 different dams) (P 
0.021 by the Mann-Whitney U
test) (Fig. 5e).
To test whether modulation
of the immune response might
restore the impairment of NPC
proliferation triggered by
poly(I·C),weinjectedtheCOX
inhibitor, carprofen, or PBS
into pregnant mice prior to treatment with poly(I · C) or PBS on
GD15 to GD17. BrdU was injected once on GD16. Flow cytomet-
ric analysis of cortical cells from PND8 pups of dams treated with
carprofen and poly(I · C) or PBS revealed no difference in either
the percentage of BrdU-labeled cells or the intensity of BrdU la-
beling (Fig. 5a to c). Similarly, the poly(I · C)-related decrease in
the percentage of BrdU-labeled, CUX1 neurons and in the in-
tensity of BrdU labeling was blocked by carprofen (Fig. 5d to f).
No signiﬁcant differences in total BrdU labeling were observed in
FIG 4 Treatment with poly(I · C) during gestation negatively regulates the transition of PAX6 radial glia (RG)
cells to TBR2 PAX6 intermediate progenitor cells (IPC) in a TLR3-dependent manner. WT C57BL/6 or
TLR3/ C57BL/6 pregnant mice were treated with either PBS or poly(I · C) for three consecutive days (GD15 to
GD17)andinjectedwithBrdUonGD16.CerebralcorticalcellswereisolatedfromembryosonGD18.Totalviable
cellswereanalyzedfortheexpressionofTBR2andPAX6byﬂowcytometry.(a)Representativehistogramsshowing
TBR2 PAX6 positive IPC in WT and TLR3/ cerebral cortical cells isolated from embryos (n  3) obtained
from mice treated with PBS or poly(I · C). The numbers above the brackets indicate the percentages of TBR2
PAX6IPC.(b)RepresentativehistogramsshowingPAX6RGinWTandTLR3/cerebralcorticalcellsisolated
from embryos obtained from PBS- and poly(I · C)-treated mice. The numbers above the brackets indicate the
percentages of PAX6 RG cells. Gating for the PAX6- or TBR2-positive cells was based on the staining observed
withtheisotypecontrol.(c)RepresentativehistogramsshowingthemeanﬂuorescenceintensityofTBR2andPAX6
expression. The mean ﬂuorescence intensity (MFI) is shown as a percentage of the maximum expression. MFI
valuesforthedifferentgroupsareindicatedasfollows:PBS-treatedgroup(redline),poly(I·C)-treatedgroup(blue
line), and isotype control group (gray line). The MFI for PBS-treated mice was 1,158.7  57.4, and the MFI for
poly(I · C)-treated mice was 809.3  28.4. (d) Representative histograms showing the MFI of PAX6 expression.
Experiments were performed with cerebral cortical cells isolated from embryos (n  3); data from one represen-
tative cortex are shown. MFI values for the different groups are indicated as follows: PBS-treated group (red line),
poly(I · C)-treated group (blue line), and isotype control group (gray line). The MFI for PBS-treated mice was
13,784.0  1,527.3, and the MFI for poly(I · C)-treated mice was 16,842.3  799.1. (e) Percentages of TBR2
PAX6IPCandPAX6RGinWTandTLR3/cerebralcorticalcellsisolatedfromembryosobtainedfromPBS-
and poly(I · C)-treated mice. Results are expressed as percentages of total viable cells. The values for PBS-treated
mice (white bars) and poly(I · C)-treated mice (hatched bars) are shown. Values that are signiﬁcantly different (P
0.05bytheMann-WhitneyUtest)comparedtothevaluesforthePBS-treatedcontrolgroupareindicatedbythe
bracketandasterisk.Valuesthataresigniﬁcantlydifferent(P0.05bytheMann-WhitneyUtest)comparedtothe
values for the PBS-treated control group are indicated by the bracket and two asterisks. The height of the box plot
showstheinterquartilerange,andthehorizontallineindicatesthemedian.Therangeisindicatedbytheerrorbars,
and the circles represent outlier values.
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dams exposed to carprofen or
not exposed to carprofen (4
pups obtained from 4 different
dams) (P  0.083 by the Mann-
WhitneyUtest)(seeFig.S2inthe
supplemental material).
Fluorescence-activated cell sort-
ing (FACS) data indicate that
carprofen pretreatment abro-
gates the poly(I · C)-induced de-
creaseinPAX6TBR2IPCand
in CUX1 neurons (data not
shown).
DISCUSSION
Maternal gestational exposure
to viruses is associated with in-
creased risk for neurodevelop-
mental disorders, including au-
tism (9, 27) and schizophrenia
(35, 36). The data are most
compelling for schizophrenia,
wherein maternal report has
beenconﬁrmedbyserology,in-
dicating increased risk in the
offspring of women exposed to
inﬂuenza virus during the sec-
ond trimester of pregnancy (2,
37). The fact that different
pathogens (e.g., inﬂuenza virus
[36], rubella virus [38], herpes-
virus [35]) are associated with
similar outcomes is consistent
with a model whereby infection
per se triggers damage. The bio-
logical plausibility of this hy-
pothesis is underscored by de-
cades of observations in rodent
models of neonatal infection
using lymphocytic choriomen-
ingitisvirus(39,40),Bornadis-
ease virus (41–43), and mumps
virus (44), wherein behavioral
disturbances have been linked
to abnormal neuroanatomy. In
mouse models of maternal in-
fection with human inﬂuenza
virusatmid-gestation,theadult
offspring displayed behavioral,
pharmacological, and histolog-
ical abnormalities (5, 10). Viral
RNA was not detected in fetal
tissue; abnormalities in the off-
spring were reproduced by ex-
posure to poly(I · C) (45).
Building on this work and that
of others who have also re-
ported neurodevelopmental
damage after gestational expo-
FIG 5 Treatment with the nonselective cyclooxygenase (COX) inhibitor carprofen prevents poly(I · C)-
induced decreases in cerebral cortical neurogenesis. WT C57BL/6 pregnant mice were treated with a subcu-
taneous dose of either carprofen or PBS, followed by intraperitoneal injection of either PBS or poly(I · C) for
three consecutive days (GD15 to GD17). On GD16, the mice were injected with BrdU. Cerebral cortical cells
were isolated from pups on postnatal day 8 (PND8), and quantiﬁcation of BrdU-labeled cells was performed
by ﬂow cytometric analysis. Gating for the BrdU-positive cells was based on the anti-BrdU antibody staining
observed with cells obtained from mice that were not injected with BrdU (negative control). (a) Representa-
tive histograms showing intracellular BrdU incorporation in cerebral cortical cells isolated from pups ob-
tained from the different groups of pregnant mice. The mice were ﬁrst injected with carprofen or PBS. Two
hourslater,themicewereinjectedwithPBSorpoly(I·C).Thefourtreatmentgroupswereasfollows(theﬁrst
injection is shown before the slash, and the second injection is shown after the slash): (i) PBS/PBS, (ii)
PBS/poly(I · C), (iii) carprofen/PBS, and (iv) carprofen/poly(I · C). The numbers above the brackets indicate
the percentages of BrdU-labeled cells. (b) Histograms showing the mean ﬂuorescence intensity (MFI) of
BrdU-labeledcellsrepresentedasapercentageofmaximumBrdUincorporation.Thetreatmentgroupsareas
explained above for panel a. The values for the different groups are indicated as follows: PBS/PBS group (red
line),carprofen/PBSgroup(purpleline),PBS/poly(I·C)group(blueline),carprofen/poly(I·C)group(green
line), and negative-control group (gray line). The MFI values for the different groups were as follows: 4,171.0
 184.4 for the PBS/PBS group, 3,348.0  204.3 for the carprofen/PBS group, 2,302.3  47.4 for the PBS/
poly(I · C) group, and 3,012.8  102.5 for the carprofen/poly(I · C) group. Experiments were performed with
cerebral cortical cells isolated from pups (n  4); data from one representative cortex are shown. (c) Percent-
age of BrdU in cerebral cortical cells from pups obtained from pregnant mice pretreated with carprofen or
not pretreated with carprofen, followed by treatment with PBS or poly(I · C). Results are expressed as
percentages of total gated cells. The values that are signiﬁcantly different (P  0.05 by the Mann-Whitney
Utest)comparedtothevaluesforthePBS-treatedcontrolgroupareindicatedbythebracketandasterisk.(d)
Representative histograms show intracellular BrdU incorporation in CUX1 cortical cells isolated from pups
obtainedfromthesametreatmentgroupsofpregnantmiceasexplainedaboveforpanela.Thenumbersabove
the brackets indicate the percentages of BrdU cells. (e) Representative histogram shows the MFI of BrdU
labeling in CUX1 cerebral cortical cells. Experiments were performed with cerebral cortical cells isolated
from pups (n  4); data from one representative cortex are shown. The values for the different groups are
indicated as follows: PBS/PBS group (red line), carprofen/PBS group (purple line), PBS/poly(I · C) group
(blue line), carprofen/poly(I · C) group (green line), and negative-control group (gray line). The MFI values
for the different groups were as follows: 9,180.3  600.5 for the PBS/PBS group, 5,218.5  624.9 for the
carprofen/PBS group, 4,453.8  253.6 for the PBS/poly(I · C) group, and 4,958.5  179.8 for the carprofen/
poly(I · C) group. (f) Percentage of BrdU CUX1 cerebral cortical cells from pups obtained from pregnant
mice treated with carprofen or not treated with carprofen, followed by treatment with PBS or poly(I · C).
Results are expressed as percentages of total CUX1 cells. Values for PBS-treated mice (white bars) and
poly(I·C)-treatedmice(hatchedbars)areshown.Thevaluesforthepoly(I·C)-treatedgrouparesigniﬁcantly
different(P  0.05bytheMann-WhitneyUtest)comparedtothevaluesforthePBS-treatedcontrolgroupas
indicated by the bracket and asterisk. The height of the box plot shows the interquartile range, and the
horizontal line indicates the median. The range is indicated by the error bars, and the circles represent outlier
values.
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to represent a wide range of viral infections.
Impaired open-ﬁeld locomotor activity was observed in the
offspring of poly(I · C)-treated WT pregnant mice on postnatal
day 8 (PND8). Sensorimotor gating, a brain function impaired in
schizophrenia and autism, deﬁnes the ability to segregate compo-
nents of a continuous stream of sensory and cognitive informa-
tion(47).Theprimarymammalianacousticstartlecircuitconsists
of three synapses, linking the auditory nerve with spinal motor
function. The relatively simple startle reﬂex is also inﬂuenced by
the forebrain circuitry and demonstrates other important forms
of behavioral plasticity, including attention, habituation, and fear
potentiation.WeobservedrobustbehavioralchangesinWTmice
thatreceivedasingleinjectionof5mg/mlofpoly(I·C).Hence,all
behavior experiments were performed with animals that received
a single dose of poly(I · C) on gestational day 16 (GD16).
Cerebral corticogenesis is accomplished by an orderly genera-
tion and radial migration of cortical neurons leading to the for-
mation of six layers in an “inside-out” pattern (48). Deep layers
(layersVandVI)arecomposedofearly-bornneurons,andupper
layers (layers II and IV) are of late-born neurons that are derived
from intermediate progenitor cells (IPC) (26, 48). We chose to
administer poly(I · C) on embryonic day 15 (ED15), ED16, and
ED17, a late time point in the rodent cortical neurodevelopment
coinciding with the cortical development of layers II and III (24,
26).Althoughitischallengingtomatchthestagesofpregnancyof
rodents and humans, the neurogenesis of cortical layer II/III,
peaking on GD16 in mice, correlates closely with the cortical de-
velopmenteventsofthesecondtrimesterofpregnancyinhumans
(postconception day, 100.4; http://translatingtime.net/) (49). On
PND8, a time point when the terminal differentiation of upper
corticallayersisachievedinmice,neuronsoccupyinglayersII/III
expressCUX1,ahomeodomaintranscriptionfactor(33,34).The
decreaseinthenumberofBrdUCUX1neuronsintheprogeny
of mice treated with poly(I · C) suggests that prenatal immune
activation can cause long-term defects in cortical development in
their offspring (see Fig. S5a, S5b, and S6 in the supplemental ma-
terial). In schizophrenia, a disorder wherein a subset of cases is
associated with maternal infection during a period of develop-
ment equivalent to the one we have tried to model here, incom-
plete clustering of neurons and disorganization in layer II of en-
torhinal, frontal, hippocampal, and anterior cingulate cortex are
amongthemostfrequentlyreportedcytoarchitectonicabnormal-
ities (10, 27).
Embryonicprogenitorcellsgeneratediverseneuronalsubtypes
by undergoing repeated cell divisions. The proliferation of neural
stem/progenitor cells (NPC) during late corticogenesis involves
asymmetrical divisions of radial glia (RG) cells in the ventricular
zone(VZ),yieldingself-renewingRGcellsandneurons.Asecond
mechanism of neuron generation in the dorsal cortex involves
production of IPC from RG cells (24, 48). IPC migrate to the
subventricular zone (SVZ), where they produce neurons through
symmetricaldivisions.Inthedevelopingbrain,sequentialexpres-
sion of multiple transcription factors is involved in control of
progenitor proliferation and neuronal fate (24, 28, 29). In this
cascade,thePAX6transcriptionfactorisinitiallyexpressedbyRG.
ThetransitionfromRGtoIPCoccurswithasequentialincreasein
the expression of TBR2, followed by a reduction in PAX6 expres-
sion. Our neuronal birth dating and double-labeling experiments
indicate that poly(I · C) induces a cell cycle arrest in embryonic
neuronal progenitor/stem cells. This is most deﬁnitively demon-
strated by an increase in the expansion of PAX6 RG stem cells
andaconcurrentdecreaseintheTBR2-expressingIPC(seeFig.S6
in the supplemental material). The majority of the BrdUhigh cells
were TBR2 PAX6 IPC; a smaller proportion represented RG
stem cells (see Fig. S3 in the supplemental material). These ﬁnd-
ings suggest that poly(I · C) treatment results in depletion of the
BrdUhigh IPC subpopulation.
Thesedatamayhaveimplicationsforunderstandingpatholog-
ical cortical development in other gyrencephalic species. In pri-
mates as well as rodents, the SVZ is the source of upper-layer
cortical neurons, and regional patterns of neurogenesis caused by
IPC proliferation in the SVZ help determine patterns of gyriﬁca-
tion (48, 50).
The Toll-like receptor (TLR) family plays a critical role in reg-
ulating the type I interferon (IFN) response as well as other in-
ﬂammatory cytokine and chemokine responses to viral patho-
gens.Immunecellsinvivoutilizedistinctivemechanismstodetect
viral RNA and to generate type I IFNs. In several viral infections,
Toll-like receptor 3 (TLR3)-independent signaling mechanisms,
suchasmitochondrialantiviralsignaling(MAVS)orTLR7/TLR9-
mediatedpathways,areresponsibleforinducinginnateimmunity
against viral pathogens (51). Poly(I · C) administration leads to
pronounced expression of proinﬂammatory cytokines through
TLR3 activation (52). Cytokine levels are altered in maternal se-
rumaswellasinamnioticﬂuid,placenta,andfetalbrainfollowing
maternal immune activation by inﬂuenza infection, as well as
through exposure to lipopolysaccharide (LPS) or poly(I · C) (37,
45,53).Smithandcolleagues,usingbehaviorasanoutcome,iden-
tiﬁedinterleukin6(IL-6)asamediatoroftheeffectsofpoly(I·C)
onfetalmurinebraindevelopment(54).Invivoadministrationof
poly(I·C)hasbeenreportedtoinduceatransient,viral-infection-
likesicknessbehavior,includingchangesinweightloss,bodytem-
perature,andanorexia(55).EliminationofTLR3inourknockout
mice largely abrogates the adverse effects of poly(I · C) on embry-
onic NPC proliferation. Despite these observations, it is unclear
that poly(I · C) effects are mediated only by immune activation of
the mother and/or the embryo. Direct effects of poly(I · C) on
neural elements have been demonstrated in vitro, with reduced
cellproliferationinWTembryoniccorticalneurospheres,butnot
inNPCderivedfromTLR3/mice(56).Theseﬁndingsarecon-
sistentwithourinvivodatawhereinTLR3expressionisrestricted
toRGstemcells(seeFig.S4inthesupplementalmaterial).Ongo-
ing experiments involving experimental transfer of TLR3/ em-
bryostoWTsurrogatedamsandviceversawillmoreconclusively
address the relative contributions of maternal and fetal immune
responses to the phenotypes induced by poly(I · C).
Poly(I · C) signals through TLR3 via an NF-B-dependent
mechanismandinducesproinﬂammatorycytokines,suchasIL-1,
IL-6, IL-8, tumor necrosis factor alpha (TNF-) and RANTES,
and type I and II interferons (17, 54). Cyclooxygenase (COX)
inhibitors, such as carprofen, are used clinically to reduce pain,
fever, and inﬂammation (57). In addition to inhibiting COX,
some nonsteroidal anti-inﬂammatory drugs (NSAIDs) suppress
the production of proinﬂammatory cytokines and IFN through
NF-B transactivation (57, 58). In our model, NSAID treatment
may counter the TLR3-dependent poly(I · C) effect through a
similar cytokine-mediated mechanism. Extrapolation from mu-
rine models to humans can be hazardous. Nonetheless, the im-
paired cerebral corticogenesis and inﬂammatory response during
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mechanism may underlie the postnatal development of behav-
ioral malfunctions characteristic of many neuropsychiatric dis-
eases. Additionally, the observation that a COX inhibitor elimi-
nates poly(I · C) effects on embryonic neuronal progenitor/stem
cell proliferation may provide a rationale for the use of anti-
inﬂammatorydrugsinprenatalinfections,duringperiodsofneu-
ral development when the fetus is particularly vulnerable to cen-
tral nervous system (CNS) damage.
MATERIALS AND METHODS
Mice. WT pregnant C57BL/6 mice on gestational day 14 (GD14) were
obtained from Harlan Laboratories (Dublin, VA). All protocols were ap-
provedbytheInstitutionalAnimalCareandUseCommitteeatColumbia
University. Congenic mice with a C57BL/6 background with Toll-like
receptor 3 (TLR3) deleted were obtained by repeated breeding of het-
erozygous B6;129S1-Tlrtm1Flv/J TLR3 knockout mice (Jackson Labora-
tory, Bar Harbor, ME) with WT C57BL/6 mice for 10 generations. Het-
erozygous mice, at each generation, carrying the TLR3 deletion were
identiﬁed by PCR analysis of total genomic DNA using primers NEO_F
(CTTGGGTGGAGAGGCTATTC), NEO_R (AGGTGAGATGACAG
GAGATC), TLR3-F (ACTCCTTTGGGGGACTTTTG), and TLR3-R
(CAGGTTCGTGCAGAAGACAA)(forwardprimersandreverseprimers
indicated by F and R, respectively, at the end of the primer designation).
After 10 generations, heterozygous mice were intercrossed, and congenic
homozygous TLR3/ mice on a C57BL/6 background were selected to
maintain the colony. In all experiments where TLR3/ mice were used,
WT pups from 3 different litters served as controls.
Injection schedule. (i) Behavioral studies. Mice received a single in-
traperitoneal (i.p.) injection on gestational day 16 of either polyinosinic-
polycytidylic potassium salt [poly(I · C)] (Sigma-Aldrich, St. Louis, MO)
(5mg/kgofbodyweight)dissolvedinphosphate-bufferedsaline(PBS)or
PBS alone.
(ii)Birthdatingandcellfateexperiments.Micereceivedthreeintra-
peritoneal injections on GD15, GD16, and GD17 of either 5 mg/kg of
poly(I · C) or PBS alone. On GD16, poly(I · C)- or PBS-treated mice also
received a single i.p. injection of the thymidine analog 5-bromo-2=-
deoxyuridine (BrdU) (Sigma-Aldrich, St. Louis, MO) dissolved in 0.9%
NaCl with 7 mM NaOH at a dosage of 50 mg/kg. To avoid possible litter
effect bias, no more than two pups per litter were used in these experi-
ments [both the PBS-treated group and the poly(I · C)-treated group
contained 7 pups obtained from 4 different litters].
(iii) Cell cycle arrest experiments. Mice were treated on GD16 with
either poly(I · C) (5 mg/kg) or PBS followed by sequential injection with
two different halogenated nucleotide analogs. Poly(I · C)- or PBS-treated
pregnant mice ﬁrst received a single injection of 5-iodo-2=-deoxyuridine
(IdU) at 50 mg/kg and a single injection of 5-chloro-2=-deoxyuridine
(CldU) at 50 mg/kg (both IdU and CldU from Sigma-Aldrich, St. Louis,
MO) 10 hours later [the PBS-treated group contained 8 pups obtained
from 4 different litters, while the poly(I · C)-treated group contained 4
pups obtained from 4 different litters].
(iv) Anti-inﬂammatory pretreatment studies. On GD15, -16, and
-17, mice were injected i.p. with either PBS or poly(I · C) 2 h after subcu-
taneous injection with either carprofen (Rimadyl; Pﬁzer Animal Health,
New York, NY) (50 mg/kg) or PBS. On GD16, mice from all dose groups
also received a single i.p. injection of BrdU (both the carprofen-treated
group and the non-carprofen-treated group contained 8 pups obtained
from 8 different litters).
Cortical cell isolation. Pregnant mice were euthanized on GD18
through CO2 inhalation followed by decapitation. The brains from em-
bryos were removed and immediately placed in ice-cold Hank’s buffered
saline solution (HBSS) (Invitrogen, Carlsbad, CA). The cortices were
trimmedandhomogenizedusingthepapainneuraltissuedissociationkit
(Miltenyi Biotec, Auburn, CA).
Antibodies. The primary antibodies used included BrdU conjugated
to ﬂuorescein isothiocyanate (BrdU-FITC) (clone BU1/75 ICR1 with
cross-reactivitytoCldU;Abcam,Cambridge,MA),BrdU(cloneB44with
cross-reactivity to IdU; Becton Dickinson, San Jose, CA), PAX6 (devel-
oped by Atsushi Kawakami and obtained from Development Studies Hy-
bridoma Bank, University of Iowa, Iowa City, IA), TBR2 and TBR2 con-
jugated to phycoerythrin (TBR2-PE) (clone 21Mgs8; eBioscience, San
Diego, CA), TLR3 (Sigma-Aldrich, St. Louis, MO), TLR3 (eBioscience,
San Diego, CA), and CUX1 (Santa Cruz Biotechnology, Santa Cruz, CA).
The secondary antibodies used included donkey anti-mouse antibody
conjugated to allophycocyanin (APC), goat anti-rabbit antibody conju-
gated to PE, donkey anti-mouse antibody conjugated to FITC, donkey
anti-rat antibody conjugated to FITC, goat anti-chicken antibody conju-
gated to Cy3, goat anti-rat conjugated to Cy2, and goat anti-mouse anti-
body conjugated to Cy5 (Jackson ImmunoResearch, West Grove, MA).
The ﬂow cytometry isotype controls were PE-conjugated rat IgG2a ,
FITC-conjugatedratIgG2a,FITC-conjugatedmouseIgG1,andAPC-
conjugated mouse IgG1  isotype (BD Biosciences, Bedford, MA).
Flow cytometry. Cortical cell suspensions were obtained from the
offspring of pregnant mice treated with PBS or poly(I · C) and injected
with PBS or BrdU. Intracellular BrdU was measured using the BrdU ﬂow
kit(BDBiosciences,Bedford,MA).Thecellswereresuspendedin50lof
staining buffer (PBS plus 1.0% fetal bovine serum [FBS]). The cells were
ﬁxed, permeabilized, and treated with DNase (30 g per tube) to expose
incorporated BrdU. The cells were resuspended in 50 l of BD Perm/ﬁx
buffer containing anti-BrdU antibody conjugated to APC (1:50) and spe-
ciﬁc relevant antibodies to detect intracellular TBR2 (1:100), CUX1 (1:
50), PAX6 (1:100), and TLR3 (1:500) antigens, followed by staining with
secondary antibodies diluted 1:1,000 (for CUX1, anti-rabbit antibody
conjugated to PE; for PAX6, anti-mouse antibody conjugated to APC or
FITC; for TLR3, anti-rat antibody conjugated to FITC). The cells that
wereisolatedfrommicethatwerenotinjectedwithBrdUbutstainedwith
anti-BrdU antibody were used as controls for gating the BrdU-positive
population. Intracellular IdU or CldU was detected using anti-BrdU an-
tibodies that cross-react with each of the nucleotide analogs (1:50). Ex-
pressionofintracellularactivatedcaspase3wasanalyzedusingthecaspase
3 active form from the monoclonal antibody apoptosis kit (1:50; BD Bio-
sciences, Bedford, MA). The cells were washed and resuspended in stain-
ing buffer and analyzed by multicolor ﬂow cytometry on an LSRII ana-
lyzer(BectonDickinson,FranklinLakes,NJ).Aftergatingtoexcludedead
cells and debris based on forward scatter and side scatter, data were ana-
lyzedusingFACSDiVaacquisitionsoftware(BectonDickinson,Franklin
Lakes, NJ) and FlowJo6.1 (Tree Star, Ashland, OR).
Open-ﬁeld locomotor activity. An automated open-ﬁeld testing
arena system was used to quantitate protoambulatory locomotor activity
in a 2-min test (Coulbourn Instruments, Allentown, PA). WT pregnant
C57BL/6 mice were treated on GD16 with either poly(I · C) (5 mg/kg) or
PBS,andlocomotoractivitywastestedintheoffspringofthetreateddams
on postnatal day 8 (PND8) [the PBS-treated group contained 37 pups
obtained from 20 different litters, while the poly(I · C)-treated group
contained 40 pups obtained from 20 different litters].
Startle and PPI session. Prepulse inhibition (PPI), an operational
measure of acoustic sensorimotor gating in which a weak prestimulus
(prepulse) attenuates the startle response to a sudden, loud noise (59), is
regarded as a robust measure of sensorimotor gating, attention, and dis-
tractibility (60). PPI was tested in adult offspring (postnatal [PN] weeks
15to17)ofWTC57BL/6micethathadbeenexposedtoeitherpoly(I·C)
(5 mg/kg) or PBS [the PBS-treated group contained 16 mice obtained
from 8 different litters, and the poly(I · C)-treated group contained 22
mice obtained from 12 different litters] on GD16. Mice were placed in
acoustically isolated startle chambers (SR-Lab; San Diego Instruments,
San Diego, CA). All PPI test sessions consisted of startle trials (pulse
alone), prepulse trials (prepulse plus pulse), and no-stimulus trials with
only background noise (nostim). Following a 5-min period for apparatus
acclimatization, ﬁve consecutive pulse-alone trials were presented to al-
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animals had 30 blocks of PPI test trials, presented in pseudorandomized
order (i.e., excluding any trials involving identical stimuli in consecutive
trials [59]). Each block consisted of one trial of either the pulse alone or a
prepulsepluspulsestimulusatoneoffourlevelsofprepulseintensityover
background or a nostim trial. The pulse-alone trial consisted of 40-ms
120-dBpulseofbroadbandnoise.Theprepulse-plus-pulsetrialsconsisted
ofa15-msnoiseprepulse,a100-msdelay,andthena40-ms120-dBstartle
pulse. The prepulse intensities were 2, 4, 8, and 16 dB above the 60-dB
background noise. The session concluded with ﬁve consecutive pulse-
alonetrials.Theintervalbetweensuccessivetrialswas12s.Areductionin
the startle magnitude in any prepulse-plus-pulse trial relative to that ob-
servedinpulse-alonetrialsdeﬁnesPPI.ThepercentPPIwascalculatedfor
each of the prepulse intensities as [(mean of pulse-alone trials  mean of
prepulse-plus-pulsetrials)/(meanofpulse-alonetrials)100%].PPIval-
ueswereaveragedacrossthefourprepulseintensitiestoproducethemean
percentPPI.Thestartlemagnitudewascalculatedastheaverageresponse
to all of the pulse-alone trials, excluding the ﬁrst and last blocks of ﬁve
pulse-alonetrials.Thehabituationofthestartleresponsewasinvestigated
bygroupingthestartletrialsintothreeblocks(5pulse-alonetrialseach,in
order of presentation) and measuring the decrease of startle magnitudes
across blocks.
Statistical analysis. StatView version 5.0.1 software (Windows ver-
sion; SAS Institute, Cary, NC) was used for all statistical analyses. Group
comparisons were carried out using analysis of variance (ANOVA) for
normally distributed data or data that became Gaussian when trans-
formed (one-way ANOVA using the dose group as the between-subject
independent variable for the primary analyses); Fisher’s protected least-
signiﬁcant difference (PLSD) test was used for post hoc comparisons.
Mann-Whitney U tests (independent variable, dose group) were used for
group comparisons requiring nonparametric analytic approaches. For
PPI test, sex effects were also examined using a 2  2  4 (sex  dose
group  prepulse intensities) split-plot ANOVA. For all tests, statistical
signiﬁcance was assumed where P  0.05.
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